Journal of Neuroinflammation,
Journal Year:
2024,
Volume and Issue:
21(1)
Published: March 13, 2024
Abstract
Tissue-resident
macrophages
play
an
important
role
in
the
local
maintenance
of
homeostasis
and
immune
surveillance.
In
central
nervous
system
(CNS),
brain
are
anatomically
divided
into
parenchymal
microglia
non-parenchymal
border-associated
(BAMs).
Among
these
cell
populations,
have
been
well-studied
for
their
roles
during
development
as
well
health
disease.
BAMs,
mostly
located
choroid
plexus,
meningeal
perivascular
spaces,
now
gaining
increased
attention
due
to
advancements
multi-omics
technologies
genetic
methodologies.
Research
on
BAMs
over
past
decade
has
focused
ontogeny,
immunophenotypes,
involvement
various
CNS
diseases,
potential
therapeutic
targets.
Unlike
microglia,
display
mixed
origins
distinct
self-renewal
capacity.
believed
regulate
neuroimmune
responses
associated
with
barriers
contribute
immune-mediated
neuropathology.
Notably,
observed
function
diverse
cerebral
pathologies,
including
Alzheimer’s
disease,
Parkinson’s
multiple
sclerosis,
ischemic
stroke,
gliomas.
The
elucidation
heterogeneity
functions
neuroinflammation
is
mesmerizing,
since
it
may
shed
light
precision
medicine
that
emphasizes
deep
insights
programming
cues
unique
microenvironment.
this
review,
we
delve
latest
findings
covering
aspects
like
origins,
capacity,
adaptability,
implications
different
disorders.
Neuropharmacology,
Journal Year:
2018,
Volume and Issue:
145, P. 230 - 246
Published: Aug. 4, 2018
Cerebral
edema
(CE)
and
resultant
intracranial
hypertension
are
associated
with
unfavorable
prognosis
in
traumatic
brain
injury
(TBI).
CE
is
a
leading
cause
of
in-hospital
mortality,
occurring
>60%
patients
mass
lesions,
∼15%
those
normal
initial
computed
tomography
scans.
After
treatment
lesions
severe
TBI,
an
important
focus
acute
neurocritical
care
evaluating
managing
the
secondary
process
hypertension.
This
review
focuses
on
contemporary
understanding
various
pathophysiologic
pathways
contributing
to
CE,
subsequent
description
potential
targeted
therapies.
There
discussion
identified
cellular/cytotoxic
contributors
as
well
mechanisms
that
influence
blood-brain-barrier
(BBB)
disruption/vasogenic
edema,
caveat
this
distinction
may
be
somewhat
artificial
since
molecular
processes
these
interrelated.
While
exhaustive
all
putative
contributions
beyond
scope
review,
roles
some
key
highlighted,
references
provided
for
further
details.
Potential
future
targets
treating
presented
based
mechanisms.
We
thus
aim
provide
translational
synopsis
present
strategies
targeting
after
TBI
context
paradigm
shift
towards
precision
medicine.
article
part
Special
Issue
entitled
"Novel
Treatments
Traumatic
Brain
Injury".
Science Immunology,
Journal Year:
2019,
Volume and Issue:
4(37)
Published: July 5, 2019
Barriers
between
circulation
and
the
central
nervous
system
(CNS)
play
a
key
role
in
development
modulation
of
CNS
immune
responses.
Structural
variations
vasculature
traversing
different
anatomical
regions
within
strongly
influence
where
how
responses
first
develop.
Here,
we
provide
an
overview
cerebrovascular
anatomy,
focusing
on
blood-CNS
interface
steady-state
immunology
compartment.
We
then
discuss
is
affected
by
influences
pathophysiological
states,
such
as
autoimmune
disease,
injury,
cerebral
ischemia,
infection.
Experimental Neurology,
Journal Year:
2020,
Volume and Issue:
329, P. 113310 - 113310
Published: April 11, 2020
Innate
immune
responses,
particularly
activation
of
macrophages
and
microglia,
are
increasingly
implicated
in
CNS
disorders.
It
is
now
appreciated
that
the
heterogeneity
functions
adopted
by
these
cells
dictates
neuropathophysiology.
Research
efforts
to
characterize
range
pro-inflammatory
anti-inflammatory
phenotypes
microglia
fueled
potential
for
inflammatory
both
exacerbate
neurodegeneration
promote
repair/disease
resolution.
The
stimulation-based,
M1/M2
classification
system
has
emerged
over
last
decade
as
a
common
language
discuss
macrophage
across
different
fields.
However,
discontinuities
between
phenotypic
markers
function
create
hurdles
utility
development
effective
immunomodulatory
therapeutics
neuroinflammation.
A
framework
approach
from
function-based
comes
rapidly
emerging
evidence
metabolic
processes
regulate
cell
activation.
This
concept
immunometabolism,
however,
only
beginning
unfold
study
yet
receive
much
focus
context
neurotrauma.
In
this
review,
we
first
current
views
limitations
neuropathological
studies.
We
then
review
literature
supporting
metabolism
regulator
vitro.
Lastly,
evaluate
regulates
phenotype
vivo
models
Alzheimer's
disease
(AD),
stroke,
traumatic
brain
injury
(TBI)
spinal
cord
(SCI).
Journal of Neuroinflammation,
Journal Year:
2021,
Volume and Issue:
18(1)
Published: Jan. 5, 2021
Abstract
Background
Traumatic
brain
injury
(TBI)
is
a
leading
cause
of
death
and
disability
worldwide.
Microglial/macrophage
activation
neuroinflammation
are
key
cellular
events
following
TBI,
but
the
regulatory
functional
mechanisms
still
not
well
understood.
Myeloid-epithelial-reproductive
tyrosine
kinase
(Mer),
member
Tyro-Axl-Mer
(TAM)
family
receptor
kinases,
regulates
multiple
features
microglial/macrophage
physiology.
However,
its
function
in
regulating
innate
immune
response
M1/M2
polarization
TBI
has
been
addressed.
The
present
study
aimed
to
evaluate
role
Mer
TBI.
Methods
controlled
cortical
impact
(CCI)
mouse
model
was
employed.
siRNA
intracerebroventricularly
administered,
recombinant
protein
S
(PS)
intravenously
applied
for
intervention.
neurobehavioral
assessments,
RT-PCR,
Western
blot,
magnetic-activated
cell
sorting,
immunohistochemistry
confocal
microscopy
analysis,
Nissl
Fluoro-Jade
B
staining,
water
content
measurement,
contusion
volume
assessment
were
performed.
Results
upregulated
acute
stage
Mechanistically,
activates
signal
transducer
activator
transcription
1
(STAT1)/suppressor
cytokine
signaling
1/3
(SOCS1/3)
pathway.
Inhibition
markedly
decreases
M2-like
while
increases
M1-like
polarization,
which
exacerbates
secondary
damage
sensorimotor
deficits
after
Recombinant
PS
exerts
beneficial
effects
mice
through
activation.
Conclusions
an
important
regulator
neuroinflammation,
may
be
considered
as
potential
target
therapeutic
intervention
Non-Coding RNA,
Journal Year:
2019,
Volume and Issue:
5(2), P. 35 - 35
Published: April 24, 2019
The
central
nervous
system
can
respond
to
threat
via
the
induction
of
an
inflammatory
response.
Under
normal
circumstances
this
response
is
tightly
controlled,
however
uncontrolled
neuroinflammation
a
hallmark
many
neurological
disorders.
MicroRNAs
are
small
non-coding
RNA
molecules
that
important
for
regulating
cellular
processes.
ability
microRNAs
modulate
signaling
area
ongoing
research,
which
has
gained
much
attention
in
recent
years.
may
either
promote
or
restrict
signaling,
and
exacerbate
ameliorate
pathological
consequences
excessive
neuroinflammation.
aim
review
summarize
mode
regulation
several
well-studied
context
neuroinflammation,
including
miR-155,
miR-146a,
miR-124,
miR-21
let-7.
Furthermore,
miRNA
deregulation
during
disorders
feature
discussed,
Multiple
Sclerosis,
Alzheimer's
disease,
Parkinson's
Prion
diseases,
Japanese
encephalitis,
Herpes
ischemic
stroke
traumatic
brain
injury.
There
also
been
considerable
interest
use
altered
microRNA
signatures
as
biomarkers
these
expression
even
serve
basis
future
therapeutic
strategies
help
treat
Chinese Journal of Traumatology,
Journal Year:
2018,
Volume and Issue:
21(3), P. 137 - 151
Published: April 24, 2018
Traumatic
brain
injury
(TBI)
remains
a
major
cause
of
death
and
disability
worldwide.
Increasing
evidence
indicates
that
TBI
is
an
important
risk
factor
for
neurodegenerative
diseases
including
Alzheimer's
disease,
Parkinson's
chronic
traumatic
encephalopathy.
Despite
improved
supportive
rehabilitative
care
patients,
unfortunately,
all
late
phase
clinical
trials
in
have
yet
to
yield
safe
effective
neuroprotective
treatment.
The
disappointing
may
be
attributed
variability
treatment
approaches
heterogeneity
the
population
patients
as
well
race
against
time
prevent
or
reduce
inexorable
cell
death.
not
just
acute
event
but
disease.
Among
many
mechanisms
involved
secondary
after
TBI,
emerging
preclinical
studies
indicate
posttraumatic
prolonged
progressive
neuroinflammation
associated
with
neurodegeneration
which
treatable
long
initiating
injury.
This
review
provides
overview
recent
understanding
cell-based
therapies
target
promote
functional
recovery
TBI.
Frontiers in Neuroendocrinology,
Journal Year:
2019,
Volume and Issue:
55, P. 100788 - 100788
Published: Sept. 9, 2019
Neuroinflammation
is
a
physiological
protective
response
in
the
context
of
infection
and
injury.
However,
neuroinflammation,
especially
if
chronic,
may
also
drive
neurodegeneration.
Neurodegenerative
diseases,
such
as
multiple
sclerosis
(MS),
Alzheimer's
disease
(AD),
Parkinson's
(PD)
traumatic
brain
injury
(TBI),
display
inflammatory
activation
microglia
astrocytes.
Intriguingly,
central
nervous
system
(CNS)
highly
steroidogenic
environment
synthesizing
steroids
de
novo,
well
metabolizing
deriving
from
circulation.
Neurosteroid
synthesis
can
be
substantially
affected
by
while,
turn,
several
steroids,
17β-estradiol,
dehydroepiandrosterone
(DHEA)
allopregnanolone,
regulate
neuroinflammatory
responses.
Here,
we
review
role
neurosteroids
neuroinflammation
MS,
AD,
PD
TBI
describe
underlying
molecular
mechanisms.
Moreover,
introduce
concept
that
synthetic
neurosteroid
analogues
could
potentially
utilized
for
treatment
neurodegenerative
diseases
future.